sovaldi
gilead sciences ireland uc - sofosbuvir - hepatitt c, kronisk - antivirale midler til systemisk bruk - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 og 5. for hepatitt c-virus (hcv) genotypen bestemt aktivitet, se kapittel 4. 4 og 5. sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 og 5. for hepatitt c-virus (hcv) genotypen bestemt aktivitet, se kapittel 4. 4 og 5.
valsartan/hydrochlorothiazide sandoz 80 mg / 12.5 mg
sandoz - københavn - valsartan / hydroklortiazid - tablett, filmdrasjert - 80 mg / 12.5 mg
valsartan/hydrochlorothiazide sandoz 160 mg / 12.5 mg
sandoz - københavn - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 12.5 mg
valsartan/hydrochlorothiazide sandoz 160 mg / 25 mg
sandoz - københavn - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 25 mg
valsartan/hydrochlorothiazide krka 80 mg / 12.5 mg
krka sverige ab - valsartan / hydroklortiazid - tablett, filmdrasjert - 80 mg / 12.5 mg
valsartan/hydrochlorothiazide krka 160 mg / 12.5 mg
krka sverige ab - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 12.5 mg
valsartan/hydrochlorothiazide krka 160 mg / 25 mg
krka sverige ab - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 25 mg
valsartan/hydrochlorothiazide krka 320 mg / 12.5 mg
krka sverige ab - valsartan / hydroklortiazid - tablett, filmdrasjert - 320 mg / 12.5 mg
valsartan/hydrochlorothiazide krka 320 mg / 25 mg
krka sverige ab - valsartan / hydroklortiazid - tablett, filmdrasjert - 320 mg / 25 mg
amlodipine/valsartan/hydrochlorothiazide mylan
mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 10 mg / 160 mg / 12.5 mg